期刊文献+

子宫内膜异位症组织中hMLH1、hMSH2蛋白的表达及意义

Expression of h MLH1,h MSH2 protein and their significance in endometriosis
下载PDF
导出
摘要 目的观察人类错配修复基因h MLH1、h MSH2蛋白在子宫内膜异位症(EMS)病灶组织中的表达变化并探讨其意义。方法选择28例EMS患者的子宫内膜异位病灶组织作为病例组,其中Ⅲ期14例、Ⅳ期14例。选择因子宫肌瘤行子宫全切术的26例患者的正常子宫内膜组织作为对照组。采用免疫组化SP法检测两组h MLH1、h MSH2蛋白的表达。比较两组h MLH1、h MSH2蛋白的阳性率,比较病例组Ⅲ、Ⅳ期患者h MLH1、h MSH2蛋白的阳性率。结果病例组、对照组h MLH1蛋白阳性率分别为71.4%(20/28)、30.8%(8/26),病例组h MLH1蛋白阳性率高于对照组(P<0.01)。病例组、对照组h MSH2蛋白的阳性率分别为53.6%(15/28)、57.7%(15/26),两组h MSH2蛋白表达差异无统计学意义。病例组Ⅲ、Ⅳ期患者h MLH1、h MSH2蛋白的阳性率差异无统计学意义(P均>0.05)。结论 EMS组织h MLH1蛋白表达增高,h MLH1蛋白表达增高可能与EMS的发病有关。 Objective To study the relationship between the human mismatch repair gene( h MLH1,h MSH2) protein expression and endometriosis( EMS). Methods A total of 28 EMS tissues were involved as case group,including 14 cases of Ⅲ stage and 14 cases of Ⅳ stage. The control group tissues were cut from normal uterus tissues of 26 laparoscopic patients after myomectomy. The expression of h MLH1 and h MSH2 protein in the two groups were measured by immunohistochemical SP technique. The positive rate of h MLH1 and h MSH2 protein in two groups was compared. The positive rate of h MLH1 and h MSH2 protein in Ⅲ,Ⅳ phase of endometriosis in case group was compared. Results The positive rate of h MLH1 protein in case group and control group was 71. 4%( 20 /28),30. 8%( 8 /26),respectively. The expression of h MLH1 protein in case group was higher than that in control group( P〈0. 01). The positive rate of h MLH2 protein in control group and control group was 53. 6%( 15 /28),57. 7%( 15 /26),respectively. The expression of h MLH2 protein in two groups was no significant difference. The expression of h MLH1 and h MLH2 in Ⅲ,Ⅳ phase patients was no significant difference. Conclusions The expression of h MLH1 protein increased in EMS tissues,which indicates that h MLH1 protein may be related with the development of EMS.
出处 《山东医药》 CAS 2014年第42期11-13,共3页 Shandong Medical Journal
基金 天津市中医 中西医结合科研专项基金资助项目(11014)
关键词 子宫内膜异位症 人类错配修复基因 DNA错配修复 endometriosis human mismatch repair gene DNA mismatch repair
  • 相关文献

参考文献14

二级参考文献71

  • 1董莉,王文革,王莉.错配修复基因hMLH1、hMSH2及p53在子宫内膜癌中的表达及意义[J].实用药物与临床,2007,10(2):71-73. 被引量:11
  • 2DoII A,Abal M,Rigsu M,et al.Novel molecular profiles of endometrial cancer-new light through old windows[J].J Steroid Biechem Mol Biol,2008,108(3-5):221-229.
  • 3Jaseur T,Boland CR.Structure and function of the components of the human DNA mismatch repair system[J].Int J Canncer,2006,119(9):2030-2035.
  • 4Chao EC,Lipkin SM.Molecular models for the tissue specificity of DNA mismatch repair-deficient carcinogenesis[J].Nucleic Acids Res,2006,34(3):840-852.
  • 5Knudsen NQ,Nielsen FC,Vinther L et al.Nuclear localization of human DNA mismatch repair protein exonuclease 1(hEXOI)[J].Nucleic Acids Res,2007,35(8):2609-2619.
  • 6HeganDC,Narayanan L,Jirik FR,et al.Differing patterns of genetic instability in mice deficient in the mismatch repair genes Pms2,Mlhl,Msh2,Msh3 and Msh6[J].Carciongenesis,2006,27(12):2042-2048.
  • 7Liu FS.Molecular carcinogenesis of endometrial cancer[J].Taiwan Residents J Obstet Gyneeol,2007,46(1):26-32.
  • 8Quehenberger F,Vasen HFA,Houwelingen HC.Risk of colorectal and endometrial cancer for carriers of mutations of the hMLHl and hMSH2 gene:correction for Ascertainment[J].J Med Genet,2005,42(6):491-496.
  • 9CToodfeUow PJ,Buttin BM,Herzog TJ,et al.Prevalence of defective DNA mismatch repair and MSH6 mutation in an unselected series of endometrial cancers[J].Prec Nad Acad Sci U S A,2003,100 (10):5908-5913.
  • 10Taylor NP,Powell MA,Gibb RK,et al.MLH3 Mutation in Endometrial Cancer[J].Cancer Res,2006,66(15):7502-7508.

共引文献207

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部